Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: Diagnostic and histogenetic implications

American Journal of Surgical Pathology

Volumn 33, Issue 8, 2009, Pages 1225-1229

  Boland, Jennifer M ^a   Folpe, Andrew L ^a   Hornick, Jason L ^b   Grogg, Karen L ^a  

^a MAYO CLINIC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clusterin; Desmin; Giant cell tumor; Pigmented villonodular synovitis

Indexed keywords

CLUSTERIN; DESMIN; PODOPLANIN;

ARTICLE; GIANT CELL TUMOR; HISTOGENESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MONONUCLEAR CELL; PROTEIN EXPRESSION; SYNOVIOCYTE; TUMOR LOCALIZATION;

CLUSTERIN; GIANT CELL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; SOFT TISSUE NEOPLASMS; SYNOVIAL MEMBRANE; TUMOR MARKERS, BIOLOGICAL;

EID: 68249129260     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181a6d86f     Document Type: Article

References (23)

1. Cupp JS, Miller MA, Montgomery KD, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007;31:970-976.
2. Dal Cin P, Sciot R, Samson I, et al. Cytogenetic characterization of tenosynovial giant cell tumors (nodular tenosynovitis). Cancer Res. 1994;54:3986-3987.
3. Fletcher CD, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. World Health Organization Classification of Tumours. Lyon: IARC Press; 2002:110-114.
4. Folpe AL, Weiss SW, Fletcher CD, et al. Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation. Mod Pathol. 1998;11:939-944.
5. Grogg KL, Lae ME, Kurtin PJ, et al. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol. 2004;28:988-998.
6. Grogg KL, Macon WR, Kurtin PJ, et al. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol. 2005;18:260-266.
7. Jaffe HL, Lichtenstein I, Sutro C. Pigmented villonodular synovitis, bursitis and tenosynovitis: a discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor of myeloplaxoma of the tendon sheath with some consideration of this tendon sheath lesion itself. Arch Pathol. 1941;31:731-765.
8. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002;34: 427-431.
9. Marsee DK, Pinkus GS, Hornick JL. Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morphol. 2009;17:102-107.
10. Mertens F, Orndal C, Mandahl N, et al. Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue. Genes Chromosomes Cancer. 1993;6:212-217.
11. Morris SW, Valentine MB, Shapiro DN, et al. Reassignment of the human CSF1 gene to chromosome 1p13-p21. Blood. 1991;78: 2013-2020.
12. Nilsson M, Hoglund M, Panagopoulos I, et al. Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors. Virchows Arch. 2002;441:475-480.
13. O'Connell JX, Fanburg JC, Rosenberg AE. Giant cell tumor of tendon sheath and pigmented villonodular synovitis: immunophenotype suggests a synovial cell origin. Hum Pathol. 1995;26:771-775.
14. Ohjimi Y, Iwasaki H, Ishiguro M, et al. Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet. 1996;90:80-85.
15. Ray RA, Morton CC, Lipinski KK, et al. Cytogenetic evidence of clonality in a case of pigmented villonodular synovitis. Cancer. 1991;67:121-125.
16. Rowlands CG, Roland B, Hwang WS, et al. Diffuse-variant tenosynovial giant cell tumor: a rare and aggressive lesion. Hum Pathol. 1994;25:423-425.
17. Sciot R, Rosai J, Dal Cin P, et al. Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol. 1999;12:576-579.
18. Somerhausen NS, Fletcher CD. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol. 2000;24:479-492.
19. Vogrincic GS, O'Connell JX, Gilks CB. Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol. 1997;28: 815-819.
20. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. 5th ed. China: Mosby/Elsevier; 2008;1258:769-788.
21. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006;103:690-695.
22. Xie Q, Chen L, Fu K, et al. Podoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas. Int J Clin Exp Pathol. 2008; 1:276-284.
23. Yu H, Gibson JA, Pinkus GS, et al. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol. 2007; 128:776-782.